Johnson & Johnson vs Uber Technologies, Inc.: Strategic Comparison

This in-depth comparison examines Johnson & Johnson and Uber Technologies, Inc. across revenue, market value, business model, competitive positioning, and long-term growth strategy. Whether you are researching Johnson & Johnson on its own, evaluating Uber Technologies, Inc., or weighing the two companies side by side, the breakdown below highlights where each company leads and where the gap between Johnson & Johnson and Uber Technologies, Inc. is widest.

On the headline numbers, Johnson & Johnson reports annual revenue of $94.2B against $52.0B for Uber Technologies, Inc., while their respective market capitalizations stand at $612.8B and $177.2B. Johnson & Johnson is headquartered in United States and Uber Technologies, Inc. operates from United States, and those different home markets shape how each company competes.

Johnson & Johnson: Johnson & Johnson began as a medical-products company in the nineteenth century and became a diversified healthcare giant. After the Kenvue separation, it is a more focused healthcare company centered on medicine and medical technology.

Uber Technologies, Inc.: Uber reported FY2025 revenue of $52.017 billion, net income attributable to Uber of $10.053 billion, and approximately 34,000 employees. Dara Khosrowshahi is CEO. The company operates Mobility, Delivery, Freight, advertising, subscriptions, and partner marketplace services.

Johnson & Johnson and Uber Technologies, Inc. pursue distinct approaches to generating revenue, and understanding how each company operates is the foundation of any fair comparison between Johnson & Johnson and Uber Technologies, Inc..

Johnson & Johnson business model: Johnson & Johnson makes money by discovering, developing, manufacturing, and selling prescription medicines and medical technologies. Innovative Medicine sells therapies in oncology, immunology, neuroscience, pulmonary hypertension, infectious disease, and cardiovascular/metabolism. MedTech sells surgery, orthopaedics, cardiovascular, and vision products to hospitals, physicians, and healthcare systems.

Uber Technologies, Inc. business model: Uber makes money from mobility service fees, delivery marketplace fees, freight brokerage, advertising, Uber One subscriptions, financial partnerships, and platform services. The company does not own most of the vehicles, restaurants, or freight assets on the platform; it monetizes demand routing, pricing, payments, matching, merchant access, and marketplace data.

The durability of a company's moat often decides long-term winners. Here is how the competitive advantages of Johnson & Johnson stack up against those of Uber Technologies, Inc..

Johnson & Johnson competitive advantage: Johnson & Johnson's advantage comes from scale, R&D depth, global regulatory capability, major oncology and immunology franchises, MedTech breadth, and a large commercial infrastructure.

Uber Technologies, Inc. competitive advantage: Uber's advantage comes from local marketplace liquidity, brand recognition, routing data, payments, driver and courier networks, merchant relationships, subscriptions, and cross-sell between Mobility and Delivery.

Future prospects matter as much as current results. The growth strategies below explain how Johnson & Johnson and Uber Technologies, Inc. each plan to expand from here.

Johnson & Johnson growth strategy: The company is investing in oncology, immunology, neuroscience, cardiovascular MedTech, electrophysiology, surgery, R&D, acquisitions, and global commercial execution.

Uber Technologies, Inc. growth strategy: Uber's growth strategy is focused on marketplace liquidity, cross-platform engagement, advertising, subscriptions, delivery scale, autonomous-vehicle partnerships, and disciplined unit economics. The pending Delivery Hero offer would extend delivery density and international market reach if it closes in the second half of 2027.

A closer look at the financial trajectory of Johnson & Johnson and Uber Technologies, Inc. rounds out the comparison.

Johnson & Johnson: Johnson & Johnson's FY2025 sales increased 6.0% to $94.193 billion. Net earnings rose to $26.804 billion, helped by operating performance and other income items. Innovative Medicine generated $60.401 billion in sales, while MedTech generated $33.792 billion.

Uber Technologies, Inc.: Uber reported FY2025 revenue of $52.017 billion, up 18% from FY2024. Net income attributable to Uber was $10.053 billion, gross bookings were $193.454 billion, trips were 13.567 billion, and MAPCs reached 202 million. The company had approximately 34,000 employees at year-end 2025.